Gould Asset Management LLC Abb Vie Inc. Transaction History

Gould Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 07, 2021	SELL	$102.3 - $112.62 $207,975 - $228,956	-2,033 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$80.49 - $108.67 $163,636 - $220,926	2,033 New	2,033 $218,000
Q4 2019 Jan 17, 2020	SELL	$72.13 - $90.25 $224,252 - $280,587	-3,109 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $195,804 - $235,413	3,109 New	3,109 $235,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Gould Asset Management LLC , based on Form 13F filings with the SEC.

Stay updated on Gould Asset Management LLC with notifications on news.